Show simple item record

dc.contributor.authorHendry, Jolyon H
dc.contributor.authorRoberts, Stephen A
dc.date.accessioned2010-06-10T08:48:26Z
dc.date.available2010-06-10T08:48:26Z
dc.date.issued1991-01
dc.identifier.citationThe sensitivity of human tissues to changes in dose fractionation: deductions from the RCR survey among UK radiotherapists. 1991, 3 (1):22-7 Clin Oncol (R Coll Radiol)en
dc.identifier.issn0936-6555
dc.identifier.pmid2001338
dc.identifier.doi10.1016/S0936-6555(05)81151-3
dc.identifier.urihttp://hdl.handle.net/10541/104597
dc.description.abstractThe dosage prescriptions reported in the Royal College of Radiologists' fractionation survey among radiotherapists have been further analysed using model equations in order to deduce estimates of fractionation-sensitivity parameters for each of the six cases under consideration. For example, using the linear-quadratic model, including a (significant) time factor, with radical treatments of a T2 breast carcinoma or a T1N0 squamous carcinoma of the vocal cord, the (alpha/beta) ratios were 26 +/- 20 Gy and 37 +/- 46 Gy, respectively. The values of the time factor, expressed as the maximum extra dose required per day to counteract the decrease in effect with increasing overall time (gamma/alpha), were 0.60 and 0.45 Gy/day respectively. Using the Ellis formula, which provided a significantly better fit to the dosage prescription (P = 0.003), the exponents of N were calculated to be 0.24 +/- 0.05 and 0.27 +/- 0.07, respectively. The corresponding values of the T exponent were 0.16 +/- 0.06 and 0.014 +/- 0.075. About 20% of radiotherapists prescribed doses greater than +/- 10% from the mean fitted values for the breast treatment, and about 6% of them in the case of the vocal cord.
dc.language.isoenen
dc.subjectBreast Canceren
dc.subjectBronchial Canceren
dc.subjectCanceren
dc.subjectRectal Canceren
dc.subject.meshAged
dc.subject.meshBreast Neoplasms
dc.subject.meshBronchial Neoplasms
dc.subject.meshCarcinoma, Squamous Cell
dc.subject.meshData Interpretation, Statistical
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasms
dc.subject.meshRadiation Tolerance
dc.subject.meshRadiotherapy Dosage
dc.subject.meshRectal Neoplasms
dc.titleThe sensitivity of human tissues to changes in dose fractionation: deductions from the RCR survey among UK radiotherapists.en
dc.typeArticleen
dc.contributor.departmentCancer Research Campaign Department, Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester, UK.en
dc.identifier.journalClinical Oncologyen
html.description.abstractThe dosage prescriptions reported in the Royal College of Radiologists' fractionation survey among radiotherapists have been further analysed using model equations in order to deduce estimates of fractionation-sensitivity parameters for each of the six cases under consideration. For example, using the linear-quadratic model, including a (significant) time factor, with radical treatments of a T2 breast carcinoma or a T1N0 squamous carcinoma of the vocal cord, the (alpha/beta) ratios were 26 +/- 20 Gy and 37 +/- 46 Gy, respectively. The values of the time factor, expressed as the maximum extra dose required per day to counteract the decrease in effect with increasing overall time (gamma/alpha), were 0.60 and 0.45 Gy/day respectively. Using the Ellis formula, which provided a significantly better fit to the dosage prescription (P = 0.003), the exponents of N were calculated to be 0.24 +/- 0.05 and 0.27 +/- 0.07, respectively. The corresponding values of the T exponent were 0.16 +/- 0.06 and 0.014 +/- 0.075. About 20% of radiotherapists prescribed doses greater than +/- 10% from the mean fitted values for the breast treatment, and about 6% of them in the case of the vocal cord.


Files in this item

This item appears in the following Collection(s)

Show simple item record